Bruker (NASDAQ:BRKR) Releases FY24 Earnings Guidance

Bruker (NASDAQ:BRKR - Get Free Report) issued an update on its FY24 earnings guidance on Tuesday morning. The company provided earnings per share (EPS) guidance of $2.36-2.41 for the period, compared to the consensus estimate of $2.59. The company issued revenue guidance of $3.34-3.37 billion, compared to the consensus revenue estimate of $3.40 billion. Bruker also updated its FY 2024 guidance to 2.360-2.410 EPS.

Wall Street Analysts Forecast Growth

Several analysts have recently weighed in on BRKR shares. Wolfe Research lowered Bruker from an "outperform" rating to a "peer perform" rating in a report on Monday, September 30th. Wells Fargo & Company started coverage on shares of Bruker in a report on Tuesday, August 27th. They issued an "overweight" rating and a $78.00 price target on the stock. Barclays started coverage on shares of Bruker in a report on Tuesday, October 15th. They set an "overweight" rating and a $75.00 price objective for the company. The Goldman Sachs Group lowered their target price on shares of Bruker from $72.00 to $60.00 and set a "sell" rating on the stock in a research note on Tuesday, July 9th. Finally, Citigroup cut their price target on shares of Bruker from $95.00 to $80.00 and set a "buy" rating for the company in a research note on Wednesday, July 10th. One analyst has rated the stock with a sell rating, four have issued a hold rating and seven have assigned a buy rating to the company. Based on data from MarketBeat.com, Bruker has an average rating of "Moderate Buy" and an average price target of $80.82.

Bruker Stock Up 3.4 %

Shares of NASDAQ:BRKR traded up $1.99 during midday trading on Tuesday, hitting $61.34. The stock had a trading volume of 3,063,451 shares, compared to its average volume of 1,067,224. The company has a market cap of $9.29 billion, a P/E ratio of 24.55, a PEG ratio of 2.32 and a beta of 1.20. Bruker has a 12 month low of $54.55 and a 12 month high of $94.86. The business's 50-day simple moving average is $64.14 and its 200-day simple moving average is $66.68. The company has a quick ratio of 0.75, a current ratio of 1.65 and a debt-to-equity ratio of 1.18.

Bruker (NASDAQ:BRKR - Get Free Report) last released its quarterly earnings data on Tuesday, August 6th. The medical research company reported $0.52 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.52. The firm had revenue of $800.70 million for the quarter, compared to analyst estimates of $799.44 million. Bruker had a return on equity of 24.92% and a net margin of 11.29%. The business's revenue for the quarter was up 17.4% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.50 earnings per share. On average, sell-side analysts forecast that Bruker will post 2.61 earnings per share for the current fiscal year.

Bruker Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Monday, September 16th. Investors of record on Monday, September 2nd were given a $0.05 dividend. This represents a $0.20 dividend on an annualized basis and a dividend yield of 0.33%. The ex-dividend date was Friday, August 30th. Bruker's payout ratio is currently 8.30%.

Bruker Company Profile

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies.